Stem Cells Spin (WAR:SCS) Total Stockholders Equity: zł6.21 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

WAR:SCS Stem Cells Spin SA WAR:SCS
34 GF Score
Price zł0.44
GF Value zł0.10
Valuation Significantly Overvalued
! 2 Warning Signs
View Full Analysis

What is Stem Cells Spin Total Stockholders Equity?

Stem Cells Spin WAR:SCS -2.22% 34 Total Stockholders Equity is zł6.21 Mil as of Mar. 2026. GuruFocus rates WAR:SCS with a GF Score™ of 34/100 and a GF Value™ of zł0.10 (Significantly Overvalued). The stock has 2 warning signs investors should review.

Stem Cells Spin's Total Stockholders Equity for the quarter that ended in Mar. 2026 was zł6.21 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Stem Cells Spin's Book Value per Share for the quarter that ended in Mar. 2026 was zł0.15. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Stem Cells Spin's Debt-to-Equity for the quarter that ended in Mar. 2026 was 0.03.

Stem Cells Spin  (WAR:SCS) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Stem Cells Spin's Book Value per Share for the quarter that ended in Mar. 2026 is

Book Value per Share=(Total Stockholders Equity-Preferred Stock)/Shares Outstanding (EOP)
=(6.214-0)/41.337
=0.15

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Stem Cells Spin's Debt-to-Equity for the quarter that ended in Mar. 2026 is

Debt-to-Equity=Total Debt / Total Stockholders Equity
=(Short-Term Debt & Capital Lease Obligation + Long-Term Debt & Capital Lease Obligation) / Total Stockholders Equity
=(0.162 + 0) / 6.214
=0.03

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stem Cells Spin Total Stockholders Equity Related Terms

Stem Cells Spin Total Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Stem Cells Spin's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stem Cells Spin Total Stockholders Equity Chart

Stem Cells Spin Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.56 7.58 7.43 6.91 6.38

Stem Cells Spin Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.77 6.65 6.53 6.38 6.21
WAR:SCS
34GF Score
Stem Cells Spin SA WAR:SCS
Total Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a Total Stockholders Equity of zł6.21 Mil mean?
Stem Cells Spin (WAR:SCS) has a Total Stockholders Equity of zł6.21 Mil as of Mar. 2026. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Stem Cells Spin and its competitors.
Is Stem Cells Spin's Total Stockholders Equity too high?
Stem Cells Spin's current Total Stockholders Equity is zł6.21 Mil. Overall, Stem Cells Spin has a GF Score™ of 34/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Stem Cells Spin's Total Stockholders Equity compare to VRTX and REGN?
Stem Cells Spin's Total Stockholders Equity of zł6.21 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Stockholders Equity for a Biotechnology company?
A good Total Stockholders Equity depends on the Biotechnology industry context. However, Total Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Stockholders Equity mean?
A high Total Stockholders Equity can signal that a stock is expensive relative to its fundamentals. The total amount of shareholder's equity as recorded on a company's balance sheet. View historical data for Stem Cells Spin and its competitors. Stem Cells Spin's current Total Stockholders Equity is zł6.21 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stem Cells Spin stock overvalued right now?
Based on GuruFocus' analysis, Stem Cells Spin (WAR:SCS) is currently considered Significantly Overvalued. The stock's GF Value™ is zł0.10, compared to a current price of zł0.44 — trading 340% above its estimated fair value. The current Total Stockholders Equity is zł6.21 Mil. Stem Cells Spin's overall GF Score™ is 34/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Stockholders Equity calculated?
Total Stockholders Equity is calculated from a company's financial statements. For Stem Cells Spin (WAR:SCS), the current Total Stockholders Equity is zł6.21 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Stem Cells Spin (WAR:SCS) Overvalued in 2026?

Based on GuruFocus' analysis, Stem Cells Spin stock appears to be overvalued. The current stock price of zł0.44 is trading 340% above its estimated GF Value™ of zł0.10. GuruFocus considers Stem Cells Spin to be Significantly Overvalued.

Key valuation signals for WAR:SCS:

  • Total Stockholders Equity: zł6.21 Mil
  • GF Value™: zł0.10 vs. price of zł0.44 (340% above fair value)
  • GF Score™: 34/100 with 2 warning signs

No single metric tells the full story. See the WAR:SCS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Stem Cells Spin Business Description

Address Ulica Konopnickiej 15 b, Wroclaw, POL, 51-141
Stem Cells Spin SA is a biotechnology company. The company is engaged in the development, production, marketing, and sale of natural regenerative products for the dermocosmetic and veterinary care markets, as well as applications for the human and veterinary medical industry. Its products include NHAC Biocervin MIC-1, Revitacell, PRS MIC-1, and Velvetyna.
34GF Score

Get the complete analysis for WAR:SCS

Total Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

zł0.44
Price
zł0.10
GF Value